Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Zepp Health ( (ZEPP) ).
Zepp Health reported unaudited fourth-quarter and full-year 2025 results on March 15, 2026, highlighting strong momentum in its premium smartwatch strategy. Revenue for 2025 rose 41.8% year-on-year to US$258.9 million, while 2025 gross margin improved to 38.3%, and GAAP net loss narrowed sharply to US$40.1 million, supported by tighter cost control and a healthier capital structure with US$112.9 million in cash at year-end.
In the fourth quarter of 2025, revenue climbed 43% year-on-year to US$85.2 million and gross margin reached a record 40.4%, driven by a favorable product mix and resilient pricing during peak sales seasons. Zepp launched several new Amazfit devices and expanded its roster of elite athletes, reinforcing its push into the higher-margin performance segment, while reduced inventory, lower debt and an ongoing share repurchase program signaled improving operational discipline and a focus on shareholder value.
The most recent analyst rating on (ZEPP) stock is a Hold with a $17.50 price target. To see the full list of analyst forecasts on Zepp Health stock, see the ZEPP Stock Forecast page.
Spark’s Take on ZEPP Stock
According to Spark, TipRanks’ AI Analyst, ZEPP is a Neutral.
The score is held down primarily by weak multi-year financial performance (declining revenue trend, ongoing losses, and negative free cash flow) and bearish technicals (price below key moving averages with negative MACD). These are partially offset by a stronger latest earnings update featuring sharp YoY revenue growth, improving margins sequentially, improved cash position, and upbeat near-term guidance, while valuation remains difficult to support due to losses and no dividend.
To see Spark’s full report on ZEPP stock, click here.
More about Zepp Health
Zepp Health Corporation is a global smart wearables and health technology company best known for its Amazfit-branded smartwatches and fitness devices. The company is shifting from a volume-driven model toward a premium wearable and “Hybrid Training” platform, targeting performance-oriented users and athletes through higher-end products and sports community partnerships.
Average Trading Volume: 124,532
Technical Sentiment Signal: Hold
Current Market Cap: $299.3M
For an in-depth examination of ZEPP stock, go to TipRanks’ Overview page.